Theseus Pharmaceuticals I... (THRX)

AI Score

Unlock

4.07

0.01 (0.25%)

At close: Feb 13, 2024, 8:59 PM

Theseus Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q4 2020
Period Ending	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Dec 31, 2020
Cash & Equivalents	46.89M	47.47M	109.7M	94.61M	115.56M	135.09M	146.28M	244.66M	90.4M	97.59M	8.46M
Short-Term Investments	158.23M	160.74M	126.94M	103.37M	96.87M	89.7M	85.76M	n/a	n/a	n/a	n/a
Long-Term Investments	20.31M	26.03M	6.98M	13.82M	8.54M	3.81M	4.95M	n/a	n/a	n/a	n/a
Other Long-Term Assets	399K	794K	7.4M	5.9M	1.86M	1.99M	2.85M	2.95M	6.13M	2.75M	43K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	4.46M	5.55M	5.76M	4.14M	2.56M	2.72M	2.91M	3.31M	1.08M	1.74M	113K
Total Current Assets	209.59M	213.75M	236.63M	197.98M	215M	227.52M	234.95M	247.97M	91.49M	99.33M	8.57M
Property-Plant & Equipment	4.33M	4.5M	4.61M	4.75M	4.89M	4.98M	4.76M	11K	n/a	n/a	1K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	25.04M	31.32M	18.99M	24.47M	15.3M	10.77M	12.55M	2.96M	6.13M	2.75M	44K
Total Assets	234.63M	245.07M	255.62M	222.45M	230.29M	238.29M	247.5M	250.93M	97.62M	102.07M	8.61M
Account Payables	1.31M	2.42M	2.19M	4.97M	1.82M	1.5M	1.43M	1M	2.39M	1.77M	1.13M
Deferred Revenue	4.58M	4.16M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	759K	754K	748K	743K	779K	774K	1.18M	n/a	n/a	n/a	n/a
Other Current Liabilities	349K	4.51M	3.69M	5.41M	5.21M	2.93M	2.78M	2.68M	3.29M	2.2M	463K
Total Current Liabilities	7M	7.68M	6.62M	11.13M	7.81M	5.21M	5.38M	3.68M	5.68M	3.97M	1.59M
Long-Term Debt	2.9M	3.01M	3.13M	3.24M	3.34M	3.44M	3.54M	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	205K	292K	379K	466K	553K	641K	728K	815K	142.08M	142.17M	41.29M
Total Long-Term Liabilities	3.1M	3.31M	3.51M	3.7M	3.89M	4.08M	4.27M	815K	142.08M	142.17M	41.29M
Total Liabilities	10.11M	10.99M	10.13M	14.83M	11.7M	9.29M	9.65M	4.5M	147.76M	146.14M	42.88M
Total Debt	3.66M	3.77M	3.88M	3.98M	4.12M	4.22M	4.72M	n/a	n/a	n/a	n/a
Common Stock	4K	4K	4K	4K	4K	4K	4K	4K	n/a	n/a	n/a
Retained Earnings	-155.08M	-141.58M	-126.77M	-112.19M	-98.47M	-83.72M	-72.08M	-61.58M	-52.92M	-45.55M	-34.27M
Comprehensive Income	-345K	-561K	-159K	-386K	-550K	-332K	-129K	n/a	n/a	n/a	n/a
Shareholders Equity	224.52M	234.08M	245.49M	207.62M	218.59M	229M	237.85M	246.43M	-50.15M	-44.07M	-34.27M
Total Investments	178.54M	186.77M	133.91M	117.19M	105.41M	93.51M	90.7M	n/a	n/a	n/a	n/a